Frequency and structure of stimulant designer drug consumption among suspected drug users in Budapest and South-East Hungary in 2012-2013

L. Institóris, Zsófia Árok, Katalin Seprenyi, Tibor Varga, Gabriella Sára-Klausz, E. Keller, Réka A. Tóth, Leonardo Sala, Éva Kereszty, Kálmán Róna

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Identification of abuse and frequency patterns of stimulant designer drugs (SDDs) provides important information for their risk assessment and legislative control. In the present study urine and/or blood samples of suspected drug users in criminal cases were analysed by GC-MS for 38 SDDs, and for the most frequent illicit and psychoactive licit drugs in Hungary. Between July 2012 and June 2013, 2744 suspected drug users were sampled in Budapest and during 2012 and 2013, 774 persons were sampled in South-East Hungary (Csongrád County - neighbour the Romanian and Serbian borders). In Budapest 71.4% of cases, and in South-East Hungary 61% of cases were positive for at least one substance. Pentedrone was the most frequent SDD in both regions; however, the frequency distribution of the remaining drugs was highly diverse. SDDs were frequently present in combination with other drugs - generally with amphetamine or other stimulants, cannabis and/or benzodiazepines. The quarterly distribution of positive samples indicated remarkable seasonal changes in the frequency and pattern of consumption. Substances placed on the list of illicit drugs (mephedrone, 4-fluoro-amphetamine, MDPV, methylone, 4-MEC) showed a subsequent drop in frequency and were replaced by other SDDs (pentedrone, 3-MMC, methiopropamine, etc.). Newly identified compounds from seized materials were added to the list of new psychoactive substances ("Schedule C"). While the risk assessment of substances listed in Schedule C has to be performed within 2 years after scheduling, continuous monitoring of their presence and frequency among drug users is essential. In summary, our results suggest which substances should be dropped from the list of SDDs measured in biological samples; while the appearance of new substances from seized materials indicate the need for developing adequate standard analytical methods.

Original languageEnglish
Pages (from-to)181-186
Number of pages6
JournalForensic Science International
Volume248
DOIs
Publication statusPublished - Mar 1 2015

Fingerprint

Designer Drugs
Hungary
Drug Users
Amphetamine
Appointments and Schedules
Psychotropic Drugs
Street Drugs
Cannabis
Benzodiazepines
Pharmaceutical Preparations
Urine

Keywords

  • Biological samples
  • Frequency
  • Hungary
  • Stimulant designer drugs
  • Suspected drug users

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Frequency and structure of stimulant designer drug consumption among suspected drug users in Budapest and South-East Hungary in 2012-2013. / Institóris, L.; Árok, Zsófia; Seprenyi, Katalin; Varga, Tibor; Sára-Klausz, Gabriella; Keller, E.; Tóth, Réka A.; Sala, Leonardo; Kereszty, Éva; Róna, Kálmán.

In: Forensic Science International, Vol. 248, 01.03.2015, p. 181-186.

Research output: Contribution to journalArticle

Institóris, L. ; Árok, Zsófia ; Seprenyi, Katalin ; Varga, Tibor ; Sára-Klausz, Gabriella ; Keller, E. ; Tóth, Réka A. ; Sala, Leonardo ; Kereszty, Éva ; Róna, Kálmán. / Frequency and structure of stimulant designer drug consumption among suspected drug users in Budapest and South-East Hungary in 2012-2013. In: Forensic Science International. 2015 ; Vol. 248. pp. 181-186.
@article{17edf83f52024634af3f6b434ab1cb19,
title = "Frequency and structure of stimulant designer drug consumption among suspected drug users in Budapest and South-East Hungary in 2012-2013",
abstract = "Identification of abuse and frequency patterns of stimulant designer drugs (SDDs) provides important information for their risk assessment and legislative control. In the present study urine and/or blood samples of suspected drug users in criminal cases were analysed by GC-MS for 38 SDDs, and for the most frequent illicit and psychoactive licit drugs in Hungary. Between July 2012 and June 2013, 2744 suspected drug users were sampled in Budapest and during 2012 and 2013, 774 persons were sampled in South-East Hungary (Csongr{\'a}d County - neighbour the Romanian and Serbian borders). In Budapest 71.4{\%} of cases, and in South-East Hungary 61{\%} of cases were positive for at least one substance. Pentedrone was the most frequent SDD in both regions; however, the frequency distribution of the remaining drugs was highly diverse. SDDs were frequently present in combination with other drugs - generally with amphetamine or other stimulants, cannabis and/or benzodiazepines. The quarterly distribution of positive samples indicated remarkable seasonal changes in the frequency and pattern of consumption. Substances placed on the list of illicit drugs (mephedrone, 4-fluoro-amphetamine, MDPV, methylone, 4-MEC) showed a subsequent drop in frequency and were replaced by other SDDs (pentedrone, 3-MMC, methiopropamine, etc.). Newly identified compounds from seized materials were added to the list of new psychoactive substances ({"}Schedule C{"}). While the risk assessment of substances listed in Schedule C has to be performed within 2 years after scheduling, continuous monitoring of their presence and frequency among drug users is essential. In summary, our results suggest which substances should be dropped from the list of SDDs measured in biological samples; while the appearance of new substances from seized materials indicate the need for developing adequate standard analytical methods.",
keywords = "Biological samples, Frequency, Hungary, Stimulant designer drugs, Suspected drug users",
author = "L. Instit{\'o}ris and Zs{\'o}fia {\'A}rok and Katalin Seprenyi and Tibor Varga and Gabriella S{\'a}ra-Klausz and E. Keller and T{\'o}th, {R{\'e}ka A.} and Leonardo Sala and {\'E}va Kereszty and K{\'a}lm{\'a}n R{\'o}na",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.forsciint.2015.01.002",
language = "English",
volume = "248",
pages = "181--186",
journal = "Forensic Science International",
issn = "0379-0738",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Frequency and structure of stimulant designer drug consumption among suspected drug users in Budapest and South-East Hungary in 2012-2013

AU - Institóris, L.

AU - Árok, Zsófia

AU - Seprenyi, Katalin

AU - Varga, Tibor

AU - Sára-Klausz, Gabriella

AU - Keller, E.

AU - Tóth, Réka A.

AU - Sala, Leonardo

AU - Kereszty, Éva

AU - Róna, Kálmán

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Identification of abuse and frequency patterns of stimulant designer drugs (SDDs) provides important information for their risk assessment and legislative control. In the present study urine and/or blood samples of suspected drug users in criminal cases were analysed by GC-MS for 38 SDDs, and for the most frequent illicit and psychoactive licit drugs in Hungary. Between July 2012 and June 2013, 2744 suspected drug users were sampled in Budapest and during 2012 and 2013, 774 persons were sampled in South-East Hungary (Csongrád County - neighbour the Romanian and Serbian borders). In Budapest 71.4% of cases, and in South-East Hungary 61% of cases were positive for at least one substance. Pentedrone was the most frequent SDD in both regions; however, the frequency distribution of the remaining drugs was highly diverse. SDDs were frequently present in combination with other drugs - generally with amphetamine or other stimulants, cannabis and/or benzodiazepines. The quarterly distribution of positive samples indicated remarkable seasonal changes in the frequency and pattern of consumption. Substances placed on the list of illicit drugs (mephedrone, 4-fluoro-amphetamine, MDPV, methylone, 4-MEC) showed a subsequent drop in frequency and were replaced by other SDDs (pentedrone, 3-MMC, methiopropamine, etc.). Newly identified compounds from seized materials were added to the list of new psychoactive substances ("Schedule C"). While the risk assessment of substances listed in Schedule C has to be performed within 2 years after scheduling, continuous monitoring of their presence and frequency among drug users is essential. In summary, our results suggest which substances should be dropped from the list of SDDs measured in biological samples; while the appearance of new substances from seized materials indicate the need for developing adequate standard analytical methods.

AB - Identification of abuse and frequency patterns of stimulant designer drugs (SDDs) provides important information for their risk assessment and legislative control. In the present study urine and/or blood samples of suspected drug users in criminal cases were analysed by GC-MS for 38 SDDs, and for the most frequent illicit and psychoactive licit drugs in Hungary. Between July 2012 and June 2013, 2744 suspected drug users were sampled in Budapest and during 2012 and 2013, 774 persons were sampled in South-East Hungary (Csongrád County - neighbour the Romanian and Serbian borders). In Budapest 71.4% of cases, and in South-East Hungary 61% of cases were positive for at least one substance. Pentedrone was the most frequent SDD in both regions; however, the frequency distribution of the remaining drugs was highly diverse. SDDs were frequently present in combination with other drugs - generally with amphetamine or other stimulants, cannabis and/or benzodiazepines. The quarterly distribution of positive samples indicated remarkable seasonal changes in the frequency and pattern of consumption. Substances placed on the list of illicit drugs (mephedrone, 4-fluoro-amphetamine, MDPV, methylone, 4-MEC) showed a subsequent drop in frequency and were replaced by other SDDs (pentedrone, 3-MMC, methiopropamine, etc.). Newly identified compounds from seized materials were added to the list of new psychoactive substances ("Schedule C"). While the risk assessment of substances listed in Schedule C has to be performed within 2 years after scheduling, continuous monitoring of their presence and frequency among drug users is essential. In summary, our results suggest which substances should be dropped from the list of SDDs measured in biological samples; while the appearance of new substances from seized materials indicate the need for developing adequate standard analytical methods.

KW - Biological samples

KW - Frequency

KW - Hungary

KW - Stimulant designer drugs

KW - Suspected drug users

UR - http://www.scopus.com/inward/record.url?scp=84922442280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922442280&partnerID=8YFLogxK

U2 - 10.1016/j.forsciint.2015.01.002

DO - 10.1016/j.forsciint.2015.01.002

M3 - Article

VL - 248

SP - 181

EP - 186

JO - Forensic Science International

JF - Forensic Science International

SN - 0379-0738

ER -